Diagnostic approach and management of Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma):: A guide for clinicians

被引:128
作者
Hendriks, Yvonne M. C. [1 ]
de Jong, Andrea E.
Morreau, Hans
Tops, Carli M. J.
Vasen, Hans F.
Wijnen, Juul Th.
Breuning, Martijn H.
Brocker-Vriends, Annette H. J. T.
机构
[1] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands
[2] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands
关键词
D O I
10.3322/canjclin.56.4.213
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The patient with a family history for colorectal carcinoma constitutes a complicated diagnostic challenge involving many clinicians. The diagnostic workup of familial colorectal cancer is an elaborate and time consuming process in which the family and several medical specialists closely collaborate. However, establishing a diagnosis can be very rewarding. If a mutation is detected in the family, a satisfactory explanation can be provided for an accumulation of tumors at young age, and often of untimely death. Appropriate presymptomatic testing can be offered to reduce mortality among at-risk family members, and relatives not at risk can avoid uncertainty and needlessly intensive surveillance. We show the differential diagnostic considerations when an individual with a family history of colorectal carcinoma is encountered, with emphasis on Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma [HNPCC]). Practical recommendations for laboratory workup of suspected Lynch syndrome, including analysis of tumor tissue by microsatellite instability analysis and immunohistochemistry, and germline DNA analysis are given. Furthermore, the clinical management after a molecular diagnosis has been made is described. The diagnostic scheme presented here allows efficient and effective analysis of colorectal carcinoma cases with (suspected) Lynch syndrome, making optimal use of currently available technology.
引用
收藏
页码:213 / 225
页数:13
相关论文
共 90 条
[1]
AALTONEN LA, 1994, CANCER RES, V54, P1645
[2]
Hereditary intestinal cancer [J].
Aaltonen, LA .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (04) :289-298
[3]
Akiyama Y, 1997, CANCER RES, V57, P3920
[4]
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors [J].
Al-Tassan, N ;
Chmiel, NH ;
Maynard, J ;
Fleming, N ;
Livingston, AL ;
Williams, GT ;
Hodges, AK ;
Davies, DR ;
David, SS ;
Sampson, JR ;
Cheadle, JR .
NATURE GENETICS, 2002, 30 (02) :227-232
[5]
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer [J].
Bapat, BV ;
Madlensky, L ;
Temple, LKF ;
Hiruki, T ;
Redston, M ;
Baron, DL ;
Xia, L ;
Marcus, VA ;
Soravia, C ;
Mitri, A ;
Shen, W ;
Gryfe, R ;
Berk, T ;
Chodirker, BN ;
Cohen, Z ;
Gallinger, S .
HUMAN GENETICS, 1999, 104 (02) :167-176
[7]
Boland CR, 1998, CANCER RES, V58, P5248
[8]
MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
BRONNER, CE ;
BAKER, SM ;
MORRISON, PT ;
WARREN, G ;
SMITH, LG ;
LESCOE, MK ;
KANE, M ;
EARABINO, C ;
LIPFORD, J ;
LINDBLOM, A ;
TANNERGARD, P ;
BOLLAG, RJ ;
GODWIN, AR ;
WARD, DC ;
NORDENSKJOLD, M ;
FISHEL, R ;
KOLODNER, R ;
LISKAY, RM .
NATURE, 1994, 368 (6468) :258-261
[9]
Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies [J].
Bubendorf, L ;
Nocito, A ;
Moch, H ;
Sauter, G .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :72-79
[10]
Charbonnier F, 2002, CANCER RES, V62, P848